Presentation
14 March 2018 Label-free optical spectroscopy techniques for targeted, real time and informed in situ cancer diagnosis (Conference Presentation)
Author Affiliations +
Abstract
Surgery is the first-line therapy for most solid cancers, but it’s effectiveness as a cancer treatment is reduced when all cancer cells are not detected during surgery. Instead, these residual cancer cells remain leading to recurrences that negatively impact survival. We present the development and validation of handheld multimodal optical spectroscopy imaging systems to guide surgical procedures in brain, prostate and lung cancer. These systems rely on statistical models using inelastically scattered light and intrinsic tissue fluorescence spectra for live tissue classification for interventional medicine applications including surgical resection guidance and molecularly-targeted biopsy collection. These highly sensitive optical molecular imaging tools can profoundly impact a wide range of surgery and oncology procedures by improving cancer detection capabilities, reducing cancer burden, and thereby improving survival and quality of life.
Conference Presentation
© (2018) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Frédéric Leblond "Label-free optical spectroscopy techniques for targeted, real time and informed in situ cancer diagnosis (Conference Presentation)", Proc. SPIE 10478, Molecular-Guided Surgery: Molecules, Devices, and Applications IV, 1047808 (14 March 2018); https://doi.org/10.1117/12.2287890
Advertisement
Advertisement
KEYWORDS
Cancer

Oncology

Surgery

Tissue optics

Luminescence

Brain cancer

Fiber optics

Back to Top